It serves different clinical goals and uses different biological levers than levothyroxine, testosterone replacement, or corticosteroids, so the expected outcomes, monitoring, and risks differ in predictable ways
The SUSTAIN-6 trial (Marso et al., New England Journal of Medicine, 2016) showed a 26% reduction in major adverse cardiovascular events (MACE) with subcutaneous semaglutide vs placebo in patients with type 2 diabetes and high cardiovascular risk
Consume foods rich in these amino acids
Strong candidates in our Doral and Miami patient base typically present with: persistent fatigue that does not resolve with sleep, slower recovery from workouts or injury, body composition not responding proportionally to diet and training, cognitive fog without a clear clinical cause, or visible signs of accelerated aging in skin and hair